This appears to be the case in human ovarian clear cell carcinomas and endometrioid endometrial cancers, where the loss of ARID1A appears to be nearly mutually exclusive from TP53 mutations [24, 26]. The gene discussed is ARID1A; the disease is ovarian clear cell cancer.